Krsnaa Diagnostics Limited has informed the Exchange about General Updates
KRSNAA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Krsnaa Diagnostics informed the exchanges that shareholders at the 15th Annual General Meeting held on September 25, 2025 approved the continuation of Mr. Chetan Desai (DIN: 03595319) as a Non-Executive Independent Director. He will continue on the board until the end of his current tenure in April 2026, even though he will turn 75 in January 2026. This was done based on the Board of Directors' recommendation and in line with the Companies Act, 2013 and SEBI LODR rules. The disclosure was made under Regulation 30 of SEBI's Listing Obligations.
This is a routine governance disclosure and not expected to have any material impact on the stock price or shareholder value. It simply allows an existing independent director to complete his current term.